수젠텍
253840KOSDAQ의료용품 및 기타 의약 관련제품 제조업50.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
SuneTech develops and commercializes diagnostic technologies and products in multiplex immuno blot, point-of-care testing (POCT), digital healthcare, and health & beauty sectors, leveraging BIO/NANO/IT/A.I convergence. The company is expanding into personalized healthcare services and FemTech, utilizing diagnostic data for customized health and beauty solutions such as functional foods and cosmetics.
Number of Employees
153people
Average Salary
49.2M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
5.5x industry avg (excellent)
3.1x industry avg (risky)
Avg ▲17.4% (2-year basis)
Avg ▲8.9% (2-year basis)
Avg ROE -18.5% (declining, 3yr)
Detailed News Sentiment
- Positive수젠텍, 한타바이러스 美·유럽 확산에 5% 상승 [Why 바이오]
수젠텍 주가가 한타바이러스의 글로벌 확산 소식에 힘입어 4.96% 상승했다.
Detailed Momentum
Near 52w low (12%, downtrend)
1m -10.49% (falling)
Volume dry-up
Detailed Disclosure
- Neutral주식매수선택권부여에관한신고2026-05-27
- Neutral분기보고서 (2026.03)2026-05-15
